Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02687633 · ClinicalTrials.gov registry record · NA
Early Behavioral Intervention to Improve Social Communication Function in Infants With Tuberous Sclerosis Complex
A NA study of Tuberous Sclerosis Complex, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT02687633 is a NA study of Tuberous Sclerosis Complex that has completed, run by University of California, Los Angeles. The registered enrollment target is 8 participants, below the 156-participant average among 8 other Tuberous Sclerosis Complex trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02687633, a NA study of Tuberous Sclerosis Complex, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are running an intervention study for young children with Tuberous Sclerosis Complex (TSC). The study will include free play-based behavioral intervention that may improve social and communication skills in children with TSC. Eligible families will have a child in the age range of 12-36 months, with a diagnosis of TSC. A parent must also be available to attend the weekly intervention sessions at UCLA. The intervention will focus on teaching caregivers skills to improve the social and communication outcomes of their children. The content of the intervention will be individually tailored to the child's developmental level. The intervention involves pre-assessments, an intervention period of daily 60 minute sessions for 10 days, followed by weekly 60 minute sessions for 10 weeks, and post-assessments. The classroom can have up to 3 parent-child dyad and the curriculum focuses on improving social-communication and play skills.
Conditions Studied
Interventions
- BEHAVIORAL JASPER
Study Locations (1)
California
- UCLA Semel Insitute - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2015-09 |
| Est. Completion | 2017-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02687633
The ClinicalTrials.gov registry entry for NCT02687633 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 156-participant average among 8 other Tuberous Sclerosis Complex trials with a reported enrollment target (95% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tuberous Sclerosis Complex appearing as the primary indexed condition, and to 1 intervention - of which JASPER is the first listed.
NCT02687633 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02687633 about?
NCT02687633 is a clinical study titled "Early Behavioral Intervention to Improve Social Communication Function in Infants With Tuberous Sclerosis Complex". The investigators are running an intervention study for young children with Tuberous Sclerosis Complex (TSC). The study will include free play-based behavioral intervention that may improve social and communication skills in children with TSC. Eligible families will have a child in the age range of ...
What is the current status of trial NCT02687633?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2015-09. Estimated completion is 2017-08.
What conditions does trial NCT02687633 study?
This clinical trial studies the following conditions: Tuberous Sclerosis Complex.
What interventions are being tested in trial NCT02687633?
The interventions under investigation include: JASPER (BEHAVIORAL).
Who is sponsoring clinical trial NCT02687633?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02687633 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tuberous Sclerosis Complex
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
RECRUITING · Phase 2
-
Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry)
RECRUITING
-
Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution
ACTIVE NOT RECRUITING · Phase 4
-
Feasibility of [11C]Acetate-PET in LAM and TSC
ACTIVE NOT RECRUITING · Phase 1
-
Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment
ACTIVE NOT RECRUITING · Phase 3
-
Tuberous Sclerosis Complex Natural History Study: Renal Manifestations
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.